Early intervention in HIV infection: where are we?... reprinted from AIDS Research and Human Retroviruses 1994;10:893-899, Mary Ann Liebert, Inc., Publishers, New York, NY.

Detalles Bibliográficos
Publicado en:AIDS Patient Care Vol. 8; no. 6; pp. 310 - 317
Autor principal: Collier AC
Formato: tables/charts Journal Article
Publicado: Mary Ann Liebert, Inc. 1994 Dec
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=107406200&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 107406200
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        08935068
        AIP
      jtl: AIDS Patient Care
      issn: 08935068
      maglogo: N
    pubinfo:
      dt: 1994 Dec
      vid: 8
      iid: 6
      pid: 1365
      pub: Mary Ann Liebert, Inc.
      place: New Rochelle, New York
    artinfo:
      ui:
        107406200
        107406200
        1995011102
        107406200
      ppf: 310
      ppct: 7
      formats:
      tig:
        atl: Early intervention in HIV infection: where are we?... reprinted from AIDS Research and Human Retroviruses 1994;10:893-899, Mary Ann Liebert, Inc., Publishers, New York, NY.
      aug:
        au: Collier AC
        affil: Harborview Medical Center, Seattle, WA
      sug:
        subj:
          Anti-HIV Agents
          Clinical Trials
          Zidovudine Administration and Dosage
          Quality of Life
          Antigens, CD4
          Zidovudine Adverse Effects
          Survival
          Time Factors
      pubtype: Academic Journal
      doctype:
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N